awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38255333-F6BAC1A1-800A-41FE-8B3D-FF5AD5CA9B5E
Q38255333-F6BAC1A1-800A-41FE-8B3D-FF5AD5CA9B5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38255333-F6BAC1A1-800A-41FE-8B3D-FF5AD5CA9B5E
Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.
P2860
Q38255333-F6BAC1A1-800A-41FE-8B3D-FF5AD5CA9B5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38255333-F6BAC1A1-800A-41FE-8B3D-FF5AD5CA9B5E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
df1e80ffd10232624079d7e0fd11084bc88b9b07
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.